Skip to content

Dortmund, 23rd July 2025

Dr Ali Ata Tuz completed his doctorate on the causes of immunodeficiency after strokes at the Institute of Experimental Immunology and Imaging (IEII) at University Hospital Essen. The results of his research, conducted in collaboration with ISAS, were published in the journal Nature Cardiovascular Research. Having studied medicine in Turkey, Tuz has thus now obtained his doctorate in medicine in Germany. Following his doctorate, his path led him to the Bioimaging working group at ISAS. The physician researched various imaging techniques – including confocal and light sheet fluorescence microscopy – to investigate the behaviour of immune cells as a postdoctoral researcher until June 2025.

Dr. Ali Ata Tuz sitzt am Konfokalmikroskop und schaut frontal in die Kamera.. Auf dem Bildschirm nebem dem Mirkoskop sind in grün und violett Mikroskopaufnahmen von einer Probe im Mikroskop zu sehen.

Dr Ali Ata Tuz uses a confocal microscope to prepare images of immune cells in tissue sections. He will later analyse the high-resolution pictures on the computer.

© ISAS / Hannes Woidich

1. How did your path lead you from medicine into application oriented basic research?

Tuz: Right from the beginning of my medical studies in Turkey, I was interested in basic research, and I am particularly fascinated by neuroscience. I want to know how our brain works. That's why during research visits as part of my studies, for example at Yale University in the USA or at the University of Heidelberg, I studied different types of neurological disease, brain tumours or certain cell types in the brain. There is still a lot that we don't know in this field. The combination of basic research methods and clinical questions was particularly fascinating for me here. My interest in neurological and neuroimmunological research then led me to my doctorate in Germany: I want to plan and carry out experiments myself and get to know the different research methods better instead of working only in the clinical field. At the IEII in Essen, I was able to combine neuroscience and imaging, the two aspects that interest me the most, during my doctorate. Even as a post-doctoral researcher at ISAS, I still work with various imaging methods, such as light sheet fluorescence microscopy.

2. How did you proceed during your doctorate to get to the bottom of the causes of immunodeficiency after a stroke or heart attack?

Tuz: The basic idea of my doctorate was always to apply the results later in the clinic. In this field of research, we already knew that patients often have problems with infections after a stroke, something that indicates an immunodeficiency. An important part of the research process is to constantly define new research questions based on initial hypotheses and later also on the results. So we asked ourselves why this immunodeficiency occurs. If we know the cause, we can identify specific points on the signalling pathway. Researchers can then develop drugs specifically for these “targets”. However, there are still a lot of unanswered questions before the findings can really be applied in the clinic. For example, different times of drug administration after a stroke and the dose of the drugs still need to be researched. It is also a normal part of research that we often expect certain results at the beginning and then something completely new emerges.

Article Recommendation

Tuz, A.A. Ghosh, S., Karsch, L., Ttoouli, D., Sata, S.P., Ulusoy, Ö., Kraus, A., Hoerenbaum, N., Wolf, J.-N., Lohmann, S., Zwirnlein, F., Kaygusuz, V., Lakovic, V., Tummes, H.-L., Beer, A., Gallert, M., Thiebes, S., Qefalia, A., Cibir, Z., Antler, M., Korste, S., Haj Yehia, E., Michel, L., Rassaf, T., Kaltwasser, B., Abdelrahman, H., Yusuf, A.M., Wang, C., Yin, D., Haeusler, L., Lueong, S., Richter, M., Engel, D.R., Stenzel, M., Soehnlein, O., Frank, B., Solo Nomenjanahary, M., Ho-Tin-Noé, B., Siveke, J.T., Totzeck, M., Hoffmann, D., Grüneboom, A., Hagemann, N., Hasenberg, A., Desilles, J.-P., Mazighi, M., Sickmann, A., Chen, J., Hermann, D.M., Gunzer, M., Singh, V.

(2024) Stroke and myocardial infarction induce neutrophil extracellular trap release disrupting lymphoid organ structure and immunoglobulin secretion. Nature Cardiovascular Research, Jg. 3, Nr. 5, S. 525–540.

https://doi.org/10.1038/s44161-024-00462-8

3. In your work you combine various methods, such as different microscopy techniques, mass spectrometry or AI-based 3D image analysis. What role does interdisciplinary collaboration play in your research?

Tuz: The cooperation with the different research groups has helped me a lot in analysing questions from different perspectives, and thus to achieve better results. I carried out my doctorate under the supervision of Prof. Dr Matthias Gunzer, Director of the IEIB and Head of the Biospectroscopy department at ISAS. During that time I learned a lot about different microscopy techniques, for example. I was also able to learn a lot from scientists with different backgrounds who supported me, for example, with microscopy, analysing results or planning experiments with mouse models. At ISAS, I worked closely with the Bioimaging, AMBIOM and Proteomics research groups. Prof. Dr Anika Grüneboom, who is now my research group leader here at ISAS, helped us, for example, to carry out experiments with the confocal microscope and the light sheet fluorescence microscope. We also worked a lot with colleagues from the clinic because we also analysed blood and plasma samples from patients for the publication.

(The Interview was conducted by Anna Becker.)

Share

Further articles

8th July 2025

Heart Failure Rarely Occurs on Its Own: ISAS Researchers Develop New Treatment Pillars

The symptoms, subsequent problems and therapeutic challenges of patients with heart failure are increasingly challenging for general practitioners and cardiologists. Doctors are limited in their choice of treatment options, especially for patients with additional diseases. At ISAS, researchers are therefore focussing on broadening the therapeutic spectrum.

Prof. Dr. Kristina Lorenz.
25th June 2025

New Ionisation Method: From Open Questions to Closed Plasma

Mass spectrometry only works with electrically charged, i.e. ionised, particles. Researchers often use plasma for this purpose. In a series of publications, scientists from the Miniaturisation Research Group have shed new light on this ionisation method and presented a completely new type of plasma. This does not require a continuous gas flow and is therefore particularly resource-efficient.

Cayian Tian adjusts the gas supply to the plasma.
11th June 2025

“We essentially ask ourselves the same questions”

In the ISAS cooperation project “The Secret World of the Immune System”, ISAS researchers and artists from the storyLab kiU at Dortmund University of Applied Sciences and Arts brought microscope data to life in an immersive space. Lennart Oberscheidt, research associate and visual effects (VFX) supervisor at storyLab kiU, talks about the special features of the project and the similarities between art and research in an interview.

30th May 2025

What Can't Be Missing From Your Project, Laxmikanth Kollipara?

In many research projects, there is one thing that is essential for success. Perhaps a rare sample or a special device? For Dr Laxmikanth Kollipara, that one thing is a very special pillar from the PIPMet project.

Dr Laxmikanth Kollipara stands in the laboratory holding a silver-coloured column. In the background are HPLC systems.
14th May 2025

“Moving to ISAS changed my whole view on mass spectrometry”

Prof Dr Miloš Filipović is researching the connection between ageing processes and gasotransmitter signalling pathways, in particular hydrogen sulphide. The biochemist headed the ERC Sulfaging group at ISAS from October 2020 until February 2025, at which point he was appointed to the University of Glasgow in Scotland. In this interview, he looks back on the past four and a half years in Dortmund and talks about his experiences at ISAS.

Dr. habil. Milos Filipovic.
30th April 2025

Humboldt Fellow Prof Dr Xiaowei Xu started at ISAS in March

Prof Dr Xiaowei Xu from the Chinese Guangdong Cardiovascular Institute is researching the clinical application of artificial intelligence (AI) in the context of cardiovascular diseases. For 18 months in total, he will be researching various AI methods for analysing cell images as a Humboldt Fellow at ISAS.

Prof Dr Xiaowei Xu in front of the ISAS city building.
22nd April 2025

Valuable Connections: Dr Mohammad Ibrahim AlWahsh

Dr Mohammad Ibrahim AlWahsh worked as a research assistant at ISAS during his doctorate. He is now Vice Dean of the Faculty of Pharmacy and Assistant Professor of Toxicological Pathology at Al-Zaytoonah University in Jordan. In the Kompakt series ‘Valuable Connections,’ he reports on his time at ISAS and his ongoing network with the institute.

Mohammad Alwahsh.
9th April 2025

Bacteria & Sweets: Schoolgirls Examine their Breath at the Girls’ Day

On Girls' Day 2025, twelve schoolgirls got to know the work of researchers and technical assistants at the institute. They investigated the cause of and fight against inflammation, went on the hunt for bacteria and used ion mobility spectrometry to analyze the aromatic substances of various sweets in their breath.

Luisa Speicher erklärt drei Mädchen den Vortexmischer.
27th March 2025

Valuable Connections: Dr Jianxu Chen

Dr Jianxu Chen leads the junior research group AMBIOM - Analysis of Microscopic BIOMedical Images at ISAS since 2021. He previously worked at the Allen Institute for Cell Science in Seattle, USA. In the ISAS -Kompakt series ‘Valuable Connections’, the computer scientist reports on his move to health research and to Germany.

Portrait von Dr.  Jianxu Chen.